Duke-NUS grants TIIM Healthcare exclusive licence to commercialise technology for intelligently triaging sepsis patients using novel in hospital mortality risk measurements
Duke-NUS Medical School and TIIM Healthcare have signed an exclusive IP licensing agreement that will enable the latter to commercialise an innovative new technology designed to help hospital emergency care providers quickly and efficiently identify sepsis patients at higher risk of dying.
Read the original